Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Why and when to use this therapy to treat patients who have type 2 diabetes.
Read More »Everything You Need To Know To Prescribe An SGLT-2 Inhibitor (Part 1)
Cardiovascular Disease and Mortality in Prediabetes
Method to identify prediabetes found to impact risk of heart disease or death.
Read More »Estrogen Treatment Helps To Prevent Type 2 Diabetes
New research shows how estrogen treatment helps to control blood sugar levels after menopause.
Read More »High Risk and Mortality in Patients With Atrial Fibrillation and Diabetes
Risk for stroke significantly increased, but exceeded by heart failure
Read More »An SGLT-2 inhibitor Shows Renoprotective Benefits
Subanalysis of CANVAS program shows slower progression of kidney disease, reduction in weight, reduction in A1c and even drop in blood pressure.
Read More »Prediabetes a Pathway to Heart and Kidney Disease
Individuals with undiagnosed diabetes, prediabetes found to have high incidence of unrecognized chronic kidney disease.
Read More »A1c Crucial Prior to Any Surgery
Study finds higher hospital admissions, complications, and mortality rates among patients with increased A1c.
Read More »Effect of Fenofibrate on Cardiovascular Risk in Type 2 Diabetes
Studies find greater risk reduction following treatment of patients with dyslipidemia.
Read More »Empagliflozin Reduces Cardiovascular Mortality
Most important mediator due to changes in markers of plasma volume.
Read More »Incident Diabetes And Diabetes Treatment in Postmenopausal Women
Secondary analysis evaluates effect of Women’s Health Initiative dietary intervention.
Read More »